SignalsMonitor LIVE INTELLIGENCE
TECHNOLOGYQUIET

17 days ago

Most powerful obesity drug yet: People lost up to 25% of weight in trial

Most powerful obesity drug yet: People lost up to 25% of weight in trial

What's happening

SignalsMonitor is following this as a technology story. Ars Technica is the outlet attached so far. The first report grouped here was at 29 Sept 2026, 22:30 UTC. The headline in use is “Most powerful obesity drug yet: People lost up to 25% of weight in trial”. This note is SignalsMonitor's own briefing, not the publisher's article.

What we know

Researchers published late-stage clinical trial data today for the latest obesity drug, retatrutide—expected to be the most powerful formula yet—and the results appear in line with high expectations. Patients with obesity on the highest retatrutide dose lost an average of 25 percent of their body weight after 80 weeks, and…

Ars TechnicaRead at Ars Technica

Story timeline

Reports grouped into this story, earliest first. Exact repeats from the same outlet are collapsed.

Reported by 1 outlet

  • Ars Technica